Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Seminars in Immunopathology

Issue 5/2014

Mechanisms of Tissue Injury in Autoimmune Diseases

Content (9 Articles)

Editorial

Introduction: mechanisms of tissue injury in autoimmune diseases

Dan Eilat

Review

Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus

Tony N. Marion, Arnold E. Postlethwaite

Review

Immune sensing of nucleic acids in inflammatory skin diseases

Olivier Demaria, Jeremy Di Domizio, Michel Gilliet

Review

Mechanisms of tissue damage in arthritis

Stephan Blüml, Kurt Redlich, Josef S. Smolen

Review

Use of animal models in elucidating disease pathogenesis in IBD

Puja Vora Khanna, David Quan Shih, Talin Haritunians, Dermot Patrick McGovern, Stephan Targan

Review

Mechanisms of tissue injury in autoimmune liver diseases

Evaggelia Liaskou, Gideon M. Hirschfield, M. Eric Gershwin

Open Access Review

Insulitis in human type 1 diabetes: a comparison between patients and animal models

Peter In’t Veld

Open Access Review

Autoimmune and autoinflammatory mechanisms in uveitis

Richard W. Lee, Lindsay B. Nicholson, H. Nida Sen, Chi-Chao Chan, Lai Wei, Robert B. Nussenblatt, Andrew D. Dick

Review

Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory disease

John R. Lukens, Thirumala-Devi Kanneganti

Jul 14
Issue: 4/2014
Immunopathology of Glomerular Diseases
Nov 14
Issue: 6/2014
Immune Modulation, Properties and Models of CMV

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits